Trials / Withdrawn
WithdrawnNCT01960621
Effect of Cyclodextrin on Sensory Nerve Activity: A Novel Anti-tussive Therapy
The Effect of Cyclodextrin on Sensory Nerve Activity and the Cough Relex in Man: A Novel Anti-Tussive Therapy
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The investigators want to see whether the test drug in this research study, 2-hydroxypropyl-beta-cyclodextrin (2HPBCD), might potentially be able to improve cough in healthy volunteers. The investigators are initially recruiting healthy volunteers such as who are free from any respiratory disease and not on any concurrent medication, so there are no confusing effects from pre-existing respiratory symptoms or disease, nor interaction of any medication with the test drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cyclodextrin | intravenous |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-08-01
- Completion
- 2017-12-01
- First posted
- 2013-10-10
- Last updated
- 2019-05-23
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01960621. Inclusion in this directory is not an endorsement.